These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 21667222)
1. Requirements for generic antiepileptic medicines: a clinical perspective. Trinka E; Krämer G; Graf M J Neurol; 2011 Dec; 258(12):2128-32. PubMed ID: 21667222 [TBL] [Abstract][Full Text] [Related]
2. Generic products of antiepileptic drugs (AEDs): is it an issue? Bialer M Epilepsia; 2007 Oct; 48(10):1825-32. PubMed ID: 17850324 [TBL] [Abstract][Full Text] [Related]
3. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence. Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636 [TBL] [Abstract][Full Text] [Related]
4. Generic products of antiepileptic drugs: a perspective on bioequivalence, bioavailability, and formulation switches using Monte Carlo simulations. Karalis V; Macheras P; Bialer M CNS Drugs; 2014 Jan; 28(1):69-77. PubMed ID: 24092569 [TBL] [Abstract][Full Text] [Related]
5. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy? Holtkamp M; Theodore WH Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004 [TBL] [Abstract][Full Text] [Related]
6. Generic substitution in the treatment of epilepsy: patient and physician perceptions. Berg MJ; Gross RA; Haskins LS; Zingaro WM; Tomaszewski KJ Epilepsy Behav; 2008 Nov; 13(4):693-9. PubMed ID: 18589000 [TBL] [Abstract][Full Text] [Related]
7. Are there potential problems with generic substitution of antiepileptic drugs? A review of issues. Crawford P; Feely M; Guberman A; Kramer G Seizure; 2006 Apr; 15(3):165-76. PubMed ID: 16504545 [TBL] [Abstract][Full Text] [Related]
8. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs. Perucca E; Albani F; Capovilla G; Bernardina BD; Michelucci R; Zaccara G Epilepsia; 2006; 47 Suppl 5():16-20. PubMed ID: 17239100 [TBL] [Abstract][Full Text] [Related]
9. [The clinical and economic impact of generic drugs in the treatment of epilepsy]. Argumosa A; Herranz JL Rev Neurol; 2005 Jul 1-15; 41(1):45-9. PubMed ID: 15999330 [TBL] [Abstract][Full Text] [Related]
10. Prescribing generic antiepileptic drugs: Issues and concerns for nurse practitioners. Barrett MW J Am Acad Nurse Pract; 2010 Jun; 22(6):300-4. PubMed ID: 20536627 [TBL] [Abstract][Full Text] [Related]
11. Risk-Based Bioequivalence Recommendations for Antiepileptic Drugs. Li Z; Fang L; Jiang W; Kim MJ; Zhao L Curr Neurol Neurosci Rep; 2017 Sep; 17(11):82. PubMed ID: 28929357 [TBL] [Abstract][Full Text] [Related]
12. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes. Andermann F; Duh MS; Gosselin A; Paradis PE Epilepsia; 2007 Mar; 48(3):464-9. PubMed ID: 17346246 [TBL] [Abstract][Full Text] [Related]
13. Assessing bioequivalence of generic antiepilepsy drugs. Krauss GL; Caffo B; Chang YT; Hendrix CW; Chuang K Ann Neurol; 2011 Aug; 70(2):221-8. PubMed ID: 21717495 [TBL] [Abstract][Full Text] [Related]
14. Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial. Berg M; Welty TE; Gidal BE; Diaz FJ; Krebill R; Szaflarski JP; Dworetzky BA; Pollard JR; Elder EJ; Jiang W; Jiang X; Switzer RD; Privitera MD JAMA Neurol; 2017 Aug; 74(8):919-926. PubMed ID: 28654954 [TBL] [Abstract][Full Text] [Related]
15. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability. Bialer M; Midha KK Epilepsia; 2010 Jun; 51(6):941-50. PubMed ID: 20384761 [TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of antiepileptic drugs: how close is close enough? Gidal BE Curr Neurol Neurosci Rep; 2009 Jul; 9(4):333-7. PubMed ID: 19515287 [TBL] [Abstract][Full Text] [Related]